EAST RUTHERFORD, N.J., July 26, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that second quarter 2012 financial results will be released on Wednesday, August 1, 2012 after the market closes. The Company will host a conference call to discuss the second quarter 2012 financial results.
Second Quarter 2012 Earnings Conference Call
Thursday, August 2, 2012 at 8:30 a.m. Eastern Time
1-888-312-9841 for U.S.
1-719-325-2423 for International
1-888-203-1112 for U.S.
1-719-457-0820 for International
Available through Thursday, August 9, 2012
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.
SOURCE Cambrex Corporation